Filter trials by:

Year

Indication

Phase

Type

Year: 2017

A Phase 3b/4 Randomized Double-Blind Placebo Controlled Study Of Methotrexate (Mtx) Withdrawal In Subjects With Rheumatoid Arthritis (Ra) Treated With Tofacitinib 11mg Modified Release (Mr) Formulation.
  • Year: 2017
  • Type: Musculoskeletal
  • Phase: IIIb, IV
  • Indication: Rheumatoid Arthritis
A 12 Week Randomized, Double-Blind, Double Dummy, Parallel Group, Active And Placebo-Controlled, Multicenter Study To Assess The Efficacy And Safety Profile Of Pf-06650833 In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To Methotrexate.
  • Year: 2017
  • Type: Musculoskeletal
  • Phase: II
  • Indication: Rheumatoid Arthritis
A randomised, double-blind using blinded evaluator, placebo and active controlled, pilot study to evaluate the safety and efficacy of intra articular administration of Articul One in patient with symptomatic primary knee osteoarthritis.
  • Year: 2017
  • Type: Musculoskeletal
  • Phase: II
  • Indication: Knee Osteoarthritis
A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Multiple Center, Multiple-Dose Study to Assess the Efficacy and Safety of ZYN002 Administered as a Transdermal Gel to Patients with Knee Pain due to Osteoarthritis.
  • Year: 2017
  • Type: Musculoskeletal
  • Phase: IIa
  • Indication: Knee Osteoarthritis
A Phase IIa, Randomized, Double-blinded, Placebo-controlled, Dose-finding Study for Single-Dose Administration of TLC599 in Patients with Osteoarthritis (OA) of Knee.
  • Year: 2017
  • Type: Musculoskeletal
  • Phase: IIa
  • Indication: Knee Osteoarthritis
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B).
  • Year: 2017
  • Type: Device
  • Phase: Pre-Market
  • Indication: Back and/or Leg Pain

CONNECT WITH US

Facebook Linkedin Instagram Envelope Phone

CONTACT US

CovidSafe - Newcastle Research Institute - Genesis Research Services

Disclaimer: This website provides general information only; it should not be construed as medical advice nor does it replace the need to seek medical advice from a qualified medical professional. To the maximum extent permitted by law, Genesis Research Services Pty Ltd will not be liable in any way for any injury, loss or damage suffered by you through accessing or using the information on this website. View our Privacy Policy. You are strictly prohibited from downloading, copying, altering, modifying, distributing, adapting, modifying and/or re-transmitting any or all of the content on the website for any commercial use without the written consent of Genesis Research Services.